Bronchogen
Bronchogen (AEDL) is a synthetic tetrapeptide bioregulator consisting of the amino acid sequence Alanine-Glutamic acid-Aspartic acid-Leucine. Developed as part of Vladimir Khavinson’s bioregulator peptide research programme at the St. Petersburg Institute of Bioregulation and Gerontology, it belongs to a class of short peptides capable of penetrating cellular and nuclear membranes to interact directly with DNA.
Bronchogen preferentially binds to CNG sequences (targets for cytosine methylation) and the guanine N7 site, stabilising DNA structure and modulating chromatin via histone interactions.
RESEARCH USE ONLY, NOT FOR HUMAN CONSUMPTION
This product is supplied strictly as a research-grade chemical for laboratory and scientific research use only. It is not a therapeutic good, is not registered on the ARTG, and has not been assessed by the TGA for safety, quality, or efficacy. Not for human or veterinary consumption, ingestion, injection, or any in-vivo application. By purchasing you confirm you are 18+ and acquiring this product solely for lawful research purposes.
Bronchogen Specifications
Storage & handling
Store lyophilised at -20°C, protected from light. Reconstitute with bacteriostatic water for research handling and keep reconstituted material refrigerated. Shipped in insulated, temperature-controlled packaging from our Melbourne facility.